Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
SK Discovery Co., Ltd. (006120.KS)
Seongnam-si, KR
SK Discovery Co., Ltd. is a diversified enterprise operating globally and domestically in South Korea through its subsidiaries. The company's operations span several key sectors: it develops and supplies environmentally conscious materials, including biomaterials, advanced composites, high-performance substances, and energy-saving solutions. Furthermore, it delivers comprehensive healthcare offerings, ranging from vaccines and pharmaceuticals to patient treatment, prevention, and diagnostic services. SK Discovery is also active in the energy and chemicals domain, engaging in LPG storage, tank terminal services, and power generation. Its real estate division focuses on developing commercial properties, office buildings, urban and luxury residences, and renewable energy infrastructure such as solar and wind power facilities. Founded in 1969 and headquartered in Seongnam-si, South Korea, the company was formerly known as SK Chemicals Co., Ltd. before rebranding to SK Discovery Co., Ltd. in December 2017.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.32% | -8.51% | -20.47% | -14.55% | -24.85% | -16.53% | +13.74% | +48.09% | -4.17% | -31.94% | +468.43% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 6 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Conglomerates: +6.1%+12.4% ★ Q1'26: +36.7% (vs Q1'25)
-
EPS growth Conglomerates: +16.9%+431.2% ★ Q1'26: +281.5% (vs Q1'25)
-
FCF margin FCF growth · Conglomerates: +35.9%+0.4% Q1'26: +2.2% (vs Q1'25)
-
EBIT margin Conglomerates: +9.0%+3.6% Q1'26: +5.8% (vs Q1'25)
-
ROIC Conglomerates: +4.7%+2.4% Q1'26: +4.4% (vs Q1'25)
-
Share dilution Conglomerates: +0.0%+2.4% Q1'26: -4.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Conglomerates: 1.28×8.22× Q1'26: 6.03× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
|---|---|---|
| Revenue |
6.94T
est: 8.49B (+81,654.6%)
|
5.02T
est: 8.78B (+57,060.2%)
|
| EBITDA |
165.92B
est: 686.95M (+24,052.5%)
|
253.41B
est: 710.94M (+35,543.6%)
|
| EBIT |
116.45B
est: 444.20M (+26,116.1%)
|
146.71B
est: 459.72M (+31,814.2%)
|
| Net Income |
70.76B
|
180.38B
|
| SGA |
85.88B
est: 195.49M (+43,833.8%)
|
91.76B
est: 202.31M (+45,257.2%)
|
| EPS |
3,942.00
|
5,242.22
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-18 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-15 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 4/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Kodex MSCI Value 275290.KS | 0.87% | 198.5K | 0.30% |
| 2 | Kodex Energy&Chemicals 117460.KS | 0.67% | 113.8K | 0.45% |
| 3 | Kodex Dividend Value 325020.KS | 0.07% | 61.8K | 0.30% |
| 4 | WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L | 0.04% | 16.0K | 0.54% |
| 5 | WisdomTree Emerging Markets SmallCap Dividend Fund DGS | 0.03% | 579.1K | 0.58% |
| 6 | Kodex KOSPI 226490.KS | 0.03% | 230.7K | 0.15% |
| 7 | Kodex MSCI Momentum 275280.KS | 0.03% | 7.4K | 0.30% |
| 8 | Schwab Fundamental International Small Company Index ETF FNDC | 0.03% | 882.5K | 0.39% |
| 9 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.02% | 69.9K | 0.74% |
| 10 | Kodex Inno-Tech Active 364690.KS | 0.02% | 3.5K | 0.30% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chang-Won Chey | Chief Executive Officer & Vice Chairman | — | male |
| Cheol Kim | President & President of Green Chemicals Business | — | male |
| Hyun-ho Son | Chief Executive Officer & Director | — | male |
| Jaeyoung Choi | Head of Finance & Director | — | male |
| Jung-Il Yang | Executive Officer & Chief of Legal Affairs | — | male |
| Kwang-Suk Lee | Executive Officer & Chief of Communications | — | male |
| Mahn-Hoon Park | President, Chief Technology Officer & President of Life Science Business | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 006120.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
